Verona Pharma Ownership | Who Owns Verona Pharma?
Verona Pharma Ownership Summary
Verona Pharma is owned by 81.57% institutional investors, 4.12% insiders, and 14.32% retail investors. Ra capital management is the largest institutional shareholder, holding 9.46% of VRNA shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 1.41% of its assets in Verona Pharma shares.
VRNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Verona Pharma | 81.57% | 4.12% | 14.32% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 7.63M | 9.46% | $110.37M |
| Nea management company | 5.58M | 6.92% | $80.76M |
| Deep track capital, lp | 4.00M | 4.96% | $57.84M |
| Vivo capital | 3.55M | 4.40% | $51.33M |
| Frazier life sciences management | 3.31M | 4.11% | $47.93M |
| Maverick capital | 3.09M | 3.83% | $44.72M |
| Perceptive advisors | 2.43M | 3.02% | $35.19M |
| Federated hermes | 2.16M | 2.68% | $31.29M |
| Octagon capital advisors lp | 1.90M | 2.35% | $27.40M |
| Caligan partners lp | 1.84M | 2.28% | $26.66M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aisling capital management lp | 1.12M | 6.98% | $16.13M |
| Caligan partners lp | 1.84M | 6.23% | $26.66M |
| Nea management company | 5.58M | 6.08% | $80.76M |
| Alerce investment management | 213.00K | 6.04% | $3.08M |
| Vivo capital | 3.55M | 4.74% | $51.33M |
| Octagon capital advisors lp | 1.90M | 4.31% | $27.40M |
| Rosalind advisors | 250.00K | 2.78% | $3.62M |
| Frazier life sciences management | 3.31M | 2.24% | $47.93M |
| Knoll capital management | 200.00K | 1.95% | $2.89M |
| Deep track capital, lp | 4.00M | 1.73% | $57.84M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Maverick capital | 3.09M | 0.85% | 1.32M |
| Ra capital management | 7.63M | 1.46% | 1.31M |
| Price t rowe associates inc /md/ | 949.38K | 0.00% | 949.38K |
| Deep track capital, lp | 4.00M | 1.73% | 812.59K |
| Candriam s.c.a. | 773.00K | 0.07% | 773.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -2.86M |
| Carlyle group | - | - | -2.46M |
| Wellington management group llp | 1.57M | 0.00% | -2.34M |
| Eventide asset management | 527.78K | 0.13% | -1.66M |
| Perceptive advisors | 2.43M | 0.84% | -1.33M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Price t rowe associates inc /md/ | 949.38K | 0.00% | 949.38K | $13.73M |
| Candriam s.c.a. | 773.00K | 0.07% | 773.00K | $11.18M |
| Alerce investment management | 213.00K | 6.04% | 213.00K | $3.08M |
| Caption management | 140.00K | 0.03% | 140.00K | $2.02M |
| Td asset management | 121.60K | 0.00% | 121.60K | $1.76M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -2.00 |
| Naples money management | -100.00 |
| National bank of canada /fi/ | -150.00 |
| Eversource wealth advisors | -295.00 |
| Redwood wealth management group | -410.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 131 | 11.97% | 65,836,577 | -1.14% | 81 | 1.16% | 70 | 18.64% | 33 | 22.22% |
| Mar 31, 2024 | 117 | -4.88% | 66,592,785 | -1.29% | 84 | 75.18% | 59 | -4.84% | 27 | -6.90% |
| Dec 31, 2023 | 123 | 13.89% | 67,465,963 | 3.39% | 10 | 0.16% | 62 | 34.78% | 29 | -6.45% |
| Sep 30, 2023 | 108 | - | 65,253,179 | 3.82% | 82 | 1.26% | 46 | -6.12% | 31 | -3.13% |
| Jun 30, 2023 | 108 | 10.20% | 62,854,386 | 4.12% | 80 | 1.34% | 49 | -15.52% | 32 | 33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Federated Hermes Kaufmann Growth | 1.15M | 1.41% | - |
| Federated Hermes Kaufmann R | 1.15M | 1.41% | - |
| Bellevue Healthcare Ord | 1.10M | 1.36% | 1.10M |
| Federated Hermes Kaufmann Small Cap A | 990.00K | 1.22% | - |
| Federated Hermes Kaufmann Small Cap Grow | 990.00K | 1.22% | - |
| Jennison Health Sciences Equity | 842.08K | 1.04% | 142.84K |
| PGIM Jennison Health Sciences Z | 842.08K | 1.03% | - |
| Hood River Small-Cap Growth Instl | 793.65K | 0.97% | 243.00K |
| Candriam Eqs L Biotech C USD Cap | 773.00K | 0.95% | - |
| American Century U.S. Small Cap Growth | 767.54K | 0.94% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 18, 2024 | EBSWORTH DAVID R | - | Buy | $88.80K |
| Nov 11, 2024 | ZACCARDELLI DAVID | President and CEO | Sell | $12.00K |
| Nov 11, 2024 | Hahn Mark W | Chief Financial Officer | Sell | $12.00K |
| Nov 06, 2024 | EBSWORTH DAVID R | - | Buy | $188.88K |
| Nov 06, 2024 | ACKERMANN CHRISTINA | - | Buy | $198.39K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 3 | 17 |
| 2024 Q3 | 1 | 8 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 1 |
| 2023 Q4 | 2 | 1 |
VRNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools